Fingerprint
Dive into the research topics of 'Talazoparib in patients with advanced breast cancer and a germline BRCA mutation'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Talazoparib in patients with advanced breast cancer and a germline BRCA mutation
Jennifer K. Litton*, Hope S. Rugo, Johannes Ettl, Sara A. Hurvitz, Anthony Gonçalves, Kyung Hun Lee, Louis Fehrenbacher, Rinat Yerushalmi, Lida A. Mina, Miguel Martin, Henri Roché, Young Hyuck Im, Ruben G.W. Quek, Denka Markova, Iulia C. Tudor, Alison L. Hannah, Wolfgang Eiermann, Joanne L. Blum
*Corresponding author for this work
- University of Texas MD Anderson Cancer Center
- Seoul National University
- University of California at San Francisco
- Technical University of Munich
- University of California at Los Angeles
- Institut Paoli Calmettes
- Kaiser Permanente
- Rabin Medical Center Israel
- Banner Health
- Complutense University
- Institut Claudius Regaud
- Samsung Medical Center, Sungkyunkwan university
- Pfizer
- Interdisziplinäres Onkologisches Zentrum München
- US Oncology, Inc.
Research output: Contribution to journal › Article › peer-review
1627
Scopus
citations